Clinical trials in systemic lupus erythematosus
β Scribed by Jill P. Buyon
- Book ID
- 107554325
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 74 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1523-3774
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective In a crossβsectional study, we previously identified 2 potentially modifiable risk factors for adverse outcomes in systemic lupus erythematosus (SLE): selfβefficacy and social support. The goal of this study was to evaluate in a randomized controlled trial a theoryβbased i
## Abstract ## Objective Serial measurements of antiβdoubleβstranded DNA (antiβdsDNA) and complement are routine in the management of systemic lupus erythematosus (SLE), but their utility as biomarkers in preemptive treatment to prevent flares remains a subject of controversy. We hypothesized that